U.S. Markets close in 2 hrs 40 mins

Green Cross Health Limited (NZSE:GXH) Pays A NZ$0.035 Dividend In Just Four Days

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • GXH.NZ

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Green Cross Health Limited (NZSE:GXH) is about to go ex-dividend in just 4 days. The ex-dividend date is one business day before a company's record date, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is important as the process of settlement involves two full business days. So if you miss that date, you would not show up on the company's books on the record date. Accordingly, Green Cross Health investors that purchase the stock on or after the 7th of December will not receive the dividend, which will be paid on the 22nd of December.

The company's next dividend payment will be NZ$0.035 per share, and in the last 12 months, the company paid a total of NZ$0.06 per share. Calculating the last year's worth of payments shows that Green Cross Health has a trailing yield of 5.0% on the current share price of NZ$1.2. We love seeing companies pay a dividend, but it's also important to be sure that laying the golden eggs isn't going to kill our golden goose! As a result, readers should always check whether Green Cross Health has been able to grow its dividends, or if the dividend might be cut.

Check out our latest analysis for Green Cross Health

Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut.

Click here to see how much of its profit Green Cross Health paid out over the last 12 months.

historic-dividend
historic-dividend

Have Earnings And Dividends Been Growing?

Companies that aren't growing their earnings can still be valuable, but it is even more important to assess the sustainability of the dividend if it looks like the company will struggle to grow. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. With that in mind, we're not enthused to see that Green Cross Health's earnings per share have remained effectively flat over the past five years. We'd take that over an earnings decline any day, but in the long run, the best dividend stocks all grow their earnings per share.

Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Green Cross Health has delivered an average of 5.5% per year annual increase in its dividend, based on the past 10 years of dividend payments.

The Bottom Line

Is Green Cross Health worth buying for its dividend? Green Cross Health's earnings per share have not grown at all in recent years, although we like that it is paying out a low percentage of its earnings. Green Cross Health ticks a lot of boxes for us from a dividend perspective, and we think these characteristics should mark the company as deserving of further attention.

While it's tempting to invest in Green Cross Health for the dividends alone, you should always be mindful of the risks involved. For example, Green Cross Health has 2 warning signs (and 1 which is potentially serious) we think you should know about.

If you're in the market for dividend stocks, we recommend checking our list of top dividend stocks with a greater than 2% yield and an upcoming dividend.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.